The potential of neurotrophic tyrosine kinase (NTRK) inhibitors for treating lung cancer Article

Passiglia, Francesco, Caparica, Rafael, Giovannetti, Elisa et al. (2016). The potential of neurotrophic tyrosine kinase (NTRK) inhibitors for treating lung cancer . EXPERT OPINION ON INVESTIGATIONAL DRUGS, 25(4), 385-392. 10.1517/13543784.2016.1152261

International Collaboration

cited authors

  • Passiglia, Francesco; Caparica, Rafael; Giovannetti, Elisa; Giallombardo, Marco; Listi, Angela; Diana, Patrizia; Cirrincione, Girolamo; Caglevic, Christian; Raez, Luis E; Russo, Antonio; Rolfo, Christian

sustainable development goals

authors

publication date

  • April 2, 2016

published in

keywords

  • ADVANCED SOLID TUMORS
  • ALK INHIBITOR
  • ENTRECTINIB
  • ETV6-NTRK3 GENE FUSION
  • EXPRESSION
  • Life Sciences & Biomedicine
  • NTRK-inhibitors
  • NTRK1/2/3
  • ORAL PAN-TRK
  • Pharmacology & Pharmacy
  • REARRANGEMENTS
  • RECEPTOR
  • SENSITIVITY
  • Science & Technology
  • TARGETED THERAPY
  • TrkA/B/C
  • lung cancer
  • targeted therapy

Digital Object Identifier (DOI)

publisher

  • TAYLOR & FRANCIS LTD

start page

  • 385

end page

  • 392

volume

  • 25

issue

  • 4